Continuous Nerve Block vs Combination of Single Block Plus Intravenous Lidocaine for Postoperative PainRead More
Evaluation of the Extended-Release/Long-Acting Opioid Prescribing Risk Evaluation and Mitigation Strategy Program by the US Food and Drug AdministrationRead More
Axsome Therapeutics Announces AXS-07 Achieves Co-Primary and Key Secondary Endpoints in MOMENTUM Phase 3 Migraine Trial in Patients with a History of Inadequate ResponseRead More
Identification of Spinal Afferent Nerve Endings in the Colonic Mucosa and Submucosa That Communicate Directly With the Spinal Cord: The Gut-Brain Axis.Read More